Literature DB >> 19563516

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.

T B Halene1, R S Ehrlichman, Y Liang, E P Christian, G J Jonak, T L Gur, J A Blendy, H C Dow, E S Brodkin, F Schneider, R C Gur, S J Siegel.   

Abstract

N-methyl-D-aspartate receptors (NMDARs) play a pivotal role in excitatory neurotransmission, synaptic plasticity and brain development. Clinical and experimental evidence suggests a dysregulation of NMDAR function and glutamatergic pathways in the pathophysiology of schizophrenia. We evaluated electrophysiological and behavioral properties of NMDAR deficiency utilizing mice that express only 5-10% of the normal level of NMDAR NR1 subunit. Auditory and visual event related potentials yielded significantly increased amplitudes for the P20 and N40 components in NMDAR deficient (NR1(neo)-/-) mice suggesting decreased inhibitory tone. Compared to wild types, NR1(neo)-/- mice spent less time in social interactions and showed reduced nest building. NR1(neo)-/- mice displayed a preference for open arms of a zero maze and central zone of an open field, possibly reflecting decreased anxiety-related behavioral inhibition. However, locomotor activity did not differ between groups in either home cage environment or during behavioral testing. NR1(neo)-/- mice displayed hyperactivity only when placed in a large unfamiliar environment, suggesting that neither increased anxiety nor non-specific motor activation accounts for differential behavioral patterns. Data suggest that NMDAR NR1 deficiency causes disinhibition in sensory processing as well as reduced behavioral inhibition and impaired social interactions. The behavioral signature in NR1(neo)-/- mice supports the impact of impaired NMDAR function in a mouse model with possible relevance to negative symptoms in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563516      PMCID: PMC2757454          DOI: 10.1111/j.1601-183X.2009.00504.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  35 in total

Review 1.  Catching up on schizophrenia: natural history and neurobiology.

Authors:  D A Lewis; J A Lieberman
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

2.  Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol.

Authors:  Bob Oranje; Christine C Gispen-de Wied; Marinus Nicholaas Verbaten; René S Kahn
Journal:  Biol Psychiatry       Date:  2002-11-01       Impact factor: 13.382

3.  Effects of ketamine in normal and schizophrenic volunteers.

Authors:  A C Lahti; M A Weiler; B A Tamara Michaelidis; A Parwani; C A Tamminga
Journal:  Neuropsychopharmacology       Date:  2001-10       Impact factor: 7.853

Review 4.  Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.

Authors:  Klaus A Miczek; Eric W Fish; Joseph F De Bold; Rosa M M De Almeida
Journal:  Psychopharmacology (Berl)       Date:  2002-08-06       Impact factor: 4.530

Review 5.  The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

Authors:  D C Goff; J T Coyle
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

6.  Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function.

Authors:  Stephan Bickel; Hans-Peter Lipp; Daniel Umbricht
Journal:  Neuropsychopharmacology       Date:  2007-08-22       Impact factor: 7.853

7.  Cognition-enhancing and anxiolytic effects of memantine.

Authors:  Rimante Minkeviciene; Pradeep Banerjee; Heikki Tanila
Journal:  Neuropharmacology       Date:  2008-02-29       Impact factor: 5.250

8.  Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction.

Authors:  Gary E Duncan; Ken Inada; Joseph S Farrington; Beverly H Koller
Journal:  Brain Res       Date:  2008-05-08       Impact factor: 3.252

9.  Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.

Authors:  Theresa M Ballard; Meike Pauly-Evers; Guy A Higgins; Abdel-Mouttalib Ouagazzal; Vincent Mutel; Edilio Borroni; John A Kemp; Horst Bluethmann; James N C Kew
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

10.  Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice.

Authors:  Edward S Brodkin; Andrea Hagemann; Sondra Maureen Nemetski; Lee M Silver
Journal:  Brain Res       Date:  2004-03-26       Impact factor: 3.252

View more
  65 in total

1.  The CC chemokine receptor 5 regulates olfactory and social recognition in mice.

Authors:  Y V Kalkonde; R Shelton; M Villarreal; J Sigala; P K Mishra; S S Ahuja; E Barea-Rodriguez; P Moretti; S K Ahuja
Journal:  Neuroscience       Date:  2011-09-22       Impact factor: 3.590

2.  Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?

Authors:  M J Gandal; R L Anderson; E N Billingslea; G C Carlson; T P L Roberts; S J Siegel
Journal:  Genes Brain Behav       Date:  2012-08       Impact factor: 3.449

3.  Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Authors:  Valerie M Tatard-Leitman; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Eddie N Billingslea; Susumu Morita; Rachel White; Robert E Featherstone; Rabindranath Ray; Pavel I Ortinski; Anamika Banerjee; Michael J Gandal; Robert Lin; Anamaria Alexandrescu; Yuling Liang; Raquel E Gur; Karin E Borgmann-Winter; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

4.  Testing the glutamate hypothesis of schizophrenia.

Authors:  Joshua A Gordon
Journal:  Nat Neurosci       Date:  2010-01       Impact factor: 24.884

5.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

6.  Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm.

Authors:  C Kiselycznyk; P Svenningsson; E Delpire; A Holmes
Journal:  Neuroscience       Date:  2011-06-23       Impact factor: 3.590

Review 7.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

8.  Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.

Authors:  Eddie N Billingslea; Valerie M Tatard-Leitman; Jaynie Anguiano; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Susumu Morita; Robert E Featherstone; Pavel I Ortinski; Michael J Gandal; Robert Lin; Yuling Liang; Raquel E Gur; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Neuropsychopharmacology       Date:  2014-02-14       Impact factor: 7.853

9.  Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism.

Authors:  Sheryl S Moy; Natallia V Riddick; Viktoriya D Nikolova; Brian L Teng; Kara L Agster; Randal J Nonneman; Nancy B Young; Lorinda K Baker; Jessica J Nadler; James W Bodfish
Journal:  Behav Brain Res       Date:  2013-11-08       Impact factor: 3.332

10.  Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice.

Authors:  Christina L Bodarky; Tobias B Halene; Richard S Ehrlichman; Anamika Banerjee; Rabindranath Ray; Chang-Gyu Hahn; Gerald Jonak; Steven J Siegel
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.